{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:14:15Z","timestamp":1762503255335,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA233487","R37-CA222215","R41 CA243722"],"award-info":[{"award-number":["R01-CA233487","R37-CA222215","R41 CA243722"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ctro.2021.12.006","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T11:52:38Z","timestamp":1640260358000},"page":"30-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trials"],"prefix":"10.1016","volume":"33","author":[{"given":"Laila A.","family":"Gharzai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Pakela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Jaworski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issam","family":"El Naqa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew E.","family":"Spector","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol R.","family":"Bradford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven B.","family":"Chinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Malloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robbi","family":"Kupfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Shuman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaz L.","family":"Stucken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Rosko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Prince","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Casper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avraham","family":"Eisbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul L.","family":"Swiecicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Worden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle L.","family":"Mierzwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.ctro.2021.12.006_b0005","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer","volume":"324","author":"Wolf","year":"1991","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ctro.2021.12.006_b0010","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91\u201311: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.ctro.2021.12.006_b0015","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","article-title":"Larynx preservation in pyriform sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III trial","volume":"88","author":"Lefebvre","year":"1996","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"S111","key":"10.1016\/j.ctro.2021.12.006_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.mlg.0000236095.97947.26","article-title":"Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival","volume":"116","author":"Hoffman","year":"2006","journal-title":"The Laryngoscope"},{"issue":"7","key":"10.1016\/j.ctro.2021.12.006_b0025","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/lary.20477","article-title":"The Effect of treatment on survival in patients with advanced laryngeal carcinoma: Laryngeal Cancer and Survival","volume":"119","author":"Gourin","year":"2009","journal-title":"The Laryngoscope"},{"issue":"2","key":"10.1016\/j.ctro.2021.12.006_b0030","first-page":"153","article-title":"Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial","volume":"12","author":"Lorch","year":"2011","journal-title":"LancetOncol."},{"issue":"1","key":"10.1016\/j.ctro.2021.12.006_b0035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/annonc\/mdt461","article-title":"A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer","volume":"25","author":"Hitt","year":"2014","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2021.12.006_b0040","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1200\/JCO.1996.14.8.2322","article-title":"Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer","volume":"14","author":"Eisbruch","year":"1996","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2021.12.006_b0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogen repopulation during radiotherapy","volume":"27","author":"Withers","year":"1988","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2021.12.006_b0050","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2005.01.2047","article-title":"Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm","volume":"24","author":"Urba","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2021.12.006_b0055","first-page":"355","article-title":"Survival rates using individualized bioselection treatment methods in patients with advanced laryngeal cancer","volume":"143","author":"Wolf","year":"2017","journal-title":"JAMAOtolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.ctro.2021.12.006_b0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/hed.25192","article-title":"Salvage laryngectomy and laryngopharyngectomy: multicenter review of outcomes associated with a reconstructive approach","volume":"41","author":"Microvascular Committee of the American Academy of Otolaryngology-Head & Neck Surgery","year":"2019","journal-title":"Head Neck."},{"issue":"22","key":"10.1016\/j.ctro.2021.12.006_b0065","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"issue":"no. 15_suppl","key":"10.1016\/j.ctro.2021.12.006_b0070","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1200\/JCO.2019.37.15_suppl.6066","article-title":"A randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor","volume":"37","author":"Swiecicki","year":"2019","journal-title":"J Clin Oncol"},{"issue":"15_suppl","key":"10.1016\/j.ctro.2021.12.006_b0075","doi-asserted-by":"crossref","first-page":"e17539","DOI":"10.1200\/JCO.2019.37.15_suppl.e17539","volume":"37","author":"Risch","year":"2019","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2021.12.006_b0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J R Stat Soc: Ser B (Stat Method)."},{"issue":"2","key":"10.1016\/j.ctro.2021.12.006_b0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1109\/TRPMS.2018.2832609","article-title":"Development of a fully cross-validated Bayesian network approach for local control prediction in lung cancer","volume":"3","author":"Luo","year":"2019","journal-title":"IEEE Trans Radiat Plasma Med Sci"},{"key":"10.1016\/j.ctro.2021.12.006_b0090","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ (Clin Res ed)"},{"issue":"7","key":"10.1016\/j.ctro.2021.12.006_b0095","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/02841860310017595","article-title":"Laryngeal carcinoma\u2013multivariate analysis of prognostic factors in 1252 consecutive patients treated with primary radiotherapy","volume":"42","author":"Johansen","year":"2003","journal-title":"Acta Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2021.12.006_b0100","first-page":"985","article-title":"Association of quantitative metastatic lymph node burden with survival in hypopharyngeal and laryngeal cancer","volume":"4","author":"Ho","year":"2018","journal-title":"JAMAOncololgy"},{"issue":"5","key":"10.1016\/j.ctro.2021.12.006_b0105","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/hed.25075","article-title":"Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: a systematic review and meta-analysis","volume":"40","author":"Mascarella","year":"2018","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.ctro.2021.12.006_b0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4876-6","article-title":"Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study","volume":"18","author":"Cho","year":"2018","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ctro.2021.12.006_b0115","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/1754-9485.12305","article-title":"Neutrophil-to-lymphocyte ratio in head and neck cancer","volume":"59","author":"Haddad","year":"2015","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2021.12.006_b0120","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1002\/hed.25324","article-title":"Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis","volume":"40","author":"Tham","year":"2018","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.ctro.2021.12.006_b0125","first-page":"257","article-title":"Primary cancer vs competing causes of death in survivors of head and neck cancer","volume":"4","author":"Simpson","year":"2018","journal-title":"JAMAOncology"},{"issue":"10","key":"10.1016\/j.ctro.2021.12.006_b0130","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/cncr.28588","article-title":"Causes of death in long-term survivors of head and neck cancer","volume":"120","author":"Baxi","year":"2014","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.ctro.2021.12.006_b0135","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1158\/1078-0432.CCR-19-1832","article-title":"Nomogram to predict the benefit of intensive treatment for locoregionally advanced head and neck cancer","volume":"25","author":"Mell","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ctro.2021.12.006_b0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijrobp.2010.05.051","article-title":"Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy","volume":"81","author":"Hatakenaka","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2021.12.006_b0145","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.radonc.2014.01.004","article-title":"Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma","volume":"110","author":"Lambrecht","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2021.12.006_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01118","article-title":"Predictive values of MRI and PET derived quantitative parameters for patterns of failure in both p16+ and p16- high risk head and neck cancer","volume":"9","author":"Cao","year":"2019","journal-title":"Front Oncol"},{"issue":"S1","key":"10.1016\/j.ctro.2021.12.006_b0155","doi-asserted-by":"crossref","first-page":"E613","DOI":"10.1002\/hed.24051","article-title":"Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas","volume":"38","author":"Driessen","year":"2016","journal-title":"Head Neck"},{"issue":"11","key":"10.1016\/j.ctro.2021.12.006_b0160","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3174\/ajnr.A5370","article-title":"Apparent diffusion coefficient histograms of human papillomavirus-positive and human papillomavirus-negative head and neck squamous cell carcinoma: assessment of tumor heterogeneity and comparison with histopathology","volume":"38","author":"de Perrot","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"10.1016\/j.ctro.2021.12.006_b0165","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ijrobp.2008.08.024","article-title":"Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study","volume":"72","author":"Cao","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2021.12.006_b0170","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0360-3016(03)00764-8","article-title":"Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy","volume":"57","author":"Hermans","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2021.12.006_b0175","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ijrobp.2014.12.023","article-title":"Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522","volume":"91","author":"Schwartz","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.ctro.2021.12.006_b0180","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hed.23784","article-title":"Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography\/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status","volume":"37","author":"Kikuchi","year":"2015","journal-title":"Head Neck"},{"issue":"10","key":"10.1016\/j.ctro.2021.12.006_b0185","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1002\/hed.25337","article-title":"Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition staging","volume":"40","author":"Floberg","year":"2018","journal-title":"Head & Neck"},{"key":"10.1016\/j.ctro.2021.12.006_b0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.radonc.2019.05.019","article-title":"The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status","volume":"140","author":"Moan","year":"2019","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2021.12.006_b0195","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/hed.21006","article-title":"Advanced squamous cell carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy","volume":"31","author":"Chepeha","year":"2009","journal-title":"Head Neck"},{"issue":"11","key":"10.1016\/j.ctro.2021.12.006_b0200","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/hed.24883","article-title":"Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond","volume":"39","author":"de Bree","year":"2017","journal-title":"Head & Neck"},{"issue":"11","key":"10.1016\/j.ctro.2021.12.006_b0205","first-page":"1012","article-title":"Prognostic value of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma","volume":"145","author":"Spector","year":"2019","journal-title":"JAMAOtolaryngol Head Neck Surg"},{"issue":"6046","key":"10.1016\/j.ctro.2021.12.006_b0210","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630821001051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630821001051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:09:58Z","timestamp":1762502998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630821001051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":42,"alternative-id":["S2405630821001051"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2021.12.006","relation":{},"ISSN":["2405-6308"],"issn-type":[{"type":"print","value":"2405-6308"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trials","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2021.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}